Infection and Immunity, December 2000, p. 6924-6931, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Pediatrics, Leiden University Medical Center, 2300 RC, Leiden,1 and Department of Medical Microbiology,3 Department of Experimental Internal Medicine,2 and Department of Pathology,4 Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands
Received 8 March 2000/Returned for modification 24 April 2000/Accepted 24 August 2000
| |
ABSTRACT |
|---|
|
|
|---|
Elevated concentrations of interleukin-1 (IL-1) were found in
tissue surrounding biomaterials infected with Staphylococcus epidermidis. To determine the role of IL-1 in
biomaterial-associated infection (BAI), IL-1 receptor type I-deficient
(IL-1R
/
) and wild-type mice received subcutaneous
implants of silicon elastomer (SE) or polyvinylpyrrolidone-grafted SE
(SEpvp), combined with an injection of 106 CFU of S. epidermidis or sterile saline. Neither mouse strain was
susceptible to BAI around SE. IL-1R
/
mice with SEpvp
implants had a no abscess formation and a reduced susceptibility to
persistent S. epidermidis infection. The normal foreign
body response, characterized by giant-cell formation and encapsulation,
was delayed around SEpvp in wild-type mice but not in
IL-1R
/
mice. This coincided with enhanced local IL-4
production in IL-1R
/
mice. These data suggest that
inhibition of local IL-1 activity may be beneficial for the outcome of BAI.
| |
INTRODUCTION |
|---|
|
|
|---|
A variety of biomaterials, such as prosthetic heart valves, artificial joints, and catheters, are used with increasing frequency in diagnostic and therapeutic procedures in modern medicine. The use of such biomaterials has undoubtedly led to medical progress for the benefit of many patients. On the other hand, implantation of an initially sterile biomaterial may quickly be complicated by infection. The majority of biomaterial-associated infections (BAI) (40 to 75%) are caused by the relatively nonpathogenic coagulase-negative staphylococci, especially Staphylococcus epidermidis (5, 50).
The pathogenesis of BAI is still poorly understood. It is assumed that the adherence of bacteria to the implanted biomaterial is the initial step in the pathogenesis of BAI (5, 50). To prevent BAI, novel materials with modified surfaces or with coatings of an antimicrobial agent(s) to reduce bacterial adherence are being developed (4, 8, 36, 46). Adherence, however, is not the only important factor in the pathogenesis. Alterations in the host response in the vicinity of the implanted biomaterial have frequently been suggested to play a role in pathogenesis (9, 32, 54, 56, 57).
Implanted biomaterials always induce an inflammatory reaction, but the
intensity may vary, depending on the chemical composition of the
material. Exposure of human monocytes or granulocytes to biomaterials
in vitro induced the production of various cytokines (10, 12, 16,
18, 52). It was assumed that increased cytokine production might
be associated with bioincompatibility reactions, such as enhanced
leukocyte activation and enhanced susceptibility to infection. We
previously studied the infection and tissue responses around two
clinically used biomaterials, polyvinylpyrrolidone-grafted silicon
elastomer (SEpvp) and conventional silicon elastomer (SE), in mice. We
observed that subcutaneous implantation of sterile SEpvp catheter
segments was associated with an earlier and more sustained
increase in interleukin-1
(IL-1
) levels in the surrounding tissue
than implantation of sterile SE catheter segments (7, 9).
Injection of S. epidermidis along the subcutaneously
implanted SEpvp segments caused an even more pronounced and protracted
local IL-1
production, associated with subcutaneous abscesses and
with persistent infection for up to 60 days.
IL-1
and IL-1
are potent proinflammatory cytokines that have been
implicated as being important mediators in the pathogenesis of a
variety of immunological and infectious diseases (20). IL-1
exerts biological effects by an interaction with the type I IL-1
receptor (IL-1R). At present, the role of IL-1 in the pathogenesis of
BAI due to S. epidermidis is unknown. As we found an
association between increased IL-1
production and BAI
(9), we evaluated the susceptibility of IL-1R gene-deficient
(IL-1R
/
) mice to BAI caused by S. epidermidis.
(Part of these data were presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, 26 to 29 September 1999, San Francisco, Calif. [J. J. Boelens, S. A. Zaat, J. L. A. N. Murk, J. J. Weening, K. P. Dingemans, T. van der Poll, and J. Dankert, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1916, 1999].)
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals.
In total, 80 specific-pathogen-free
IL-1R
/
mice, backcrossed six times to the C57BL/6
background, and C57BL/6 wild-type mice, 6 to 8 weeks old and weighing
15 to 20 g, were used. IL-1R
/
mice (24)
were kindly provided by Immunex Co. (Seattle, Wash.) and bred in our
animal facility. Wild-type C57BL/6 mice were from Harlan, Horst, The
Netherlands. IL-1R
/
and wild-type mice were matched by
age, weight, and sex, housed in individual cages in a pathogen-free
environment, and provided with sterile food and water. The Academic
Medical Center, University of Amsterdam, Amsterdam, The Netherlands,
approved the animal experiments.
Catheter segments. Catheters of conventional SE and SEpvp (Bioglide), with a diameter of 2.5 mm and a wall thickness of 0.6 mm were obtained from Medtronic PS Medical, Goleta, Calif. One-centimeter-long segments of SE and SEpvp, cut from either catheter under aseptic conditions in a laminar flow cabinet, were stored in sterile petri dishes.
Bacterial strain. The clinical isolate S. epidermidis strain RP62a (ATCC 35984) was used. This strain is capable of producing slime, determined as described by Christensen et al. (13-15). MICs (in micrograms per milliliter) for strain RP62a, determined by the standard E test, were as follows: rifampin, <0.016; teicoplanin, 0.19; gentamicin, 256; minocyclin, <0.016; and vancomycin, 1.5. Antibiotic susceptibilities were used to confirm the identity of bacteria cultured from catheter segments and tissue homogenates.
Preparation of the bacterial inoculum. An inoculum of 106 CFU of S. epidermidis RP62a was used. We previously demonstrated that in mice injected with this inoculum along subcutaneously implanted SEpvp, macroscopic abscesses and persistent infection for up to at least 60 days were induced, while around SE neither abscess formation nor infection was observed (6, 9). Two milliliters of an overnight culture of strain RP62a in Trypticase soy broth (Difco, Detroit, Mich.) was inoculated into 100 ml of fresh Trypticase soy broth. After incubation at 37°C for 5 h, 50 ml of this culture was centrifuged at 2,200 × g for 10 min, and the pelleted bacteria were washed twice with 50 ml of pyrogen-free isotonic saline. After the final centrifugation, the pellet was resuspended in pyrogen-free isotonic saline and the optical density at 620 nm was measured. The inoculum of 106 CFU was prepared by diluting the suspension with pyrogen-free isotonic saline, based on an established relationship between bacterial concentration and optical density at 620 nm.
Subcutaneous catheter implantation and administration of the
bacterial inoculum.
Mice were anesthetized intraperitoneally with
an FFM mix (1 ml of Hypnorm [fentanylcitrate {Fluanisone}], 1 ml
of Midazalam, and 2 ml of distilled water) (0.07 ml 10 g of body
weight) and placed in a laminar flow cabinet. The backs of the mice
were shaved and prepared with 2% (wt/vol) chlorhexidine. On each side
an incision (0.3 cm) was made 0.5 cm lateral to the spine.
Subsequently, 1-cm-long SE or SEpvp catheter segments were inserted
subcutaneously. IL-1R
/
and wild-type mice received
either two SE or two SEpvp segments. The incisions were closed with a
single 0/6 vicryl stitch. Mice with implanted SE or SEpvp segments were
injected with the inoculum subcutaneously along the inserted segments
in a 25-µl volume using a repetitive pipette (Stepper model 4001-025;
Tridak Division, Brookfield, Conn.). Four IL-1R
/
mice
and four wild-type mice received a subcutaneous injection of saline
only, on both sides of the spine (saline controls).
Sample collection. Mice in the saline control group were sacrificed and evaluated at 14 days after injection. After 2, 5, or 14 days, six mice of each of the experimental groups were anesthetized with an FFM mix administered intraperitoneally and subsequently sacrificed by cardiac puncture. Sacrificed mice were placed in a laminar flow cabinet and fixed on a sterile polypropylene plate. A dorsal midline incision was made from the cervical to the lumbal area. Subsequently, the skin and subcutaneous tissue were separated from the muscle fascia up to the flank on both sides. The implantation sites were inspected for purulence, and standardized biopsies (diameter, 12 mm) were taken from the implantation sites using a specially developed tissue sampler as described previously (6). Each single biopsy included skin, subcutaneous tissue, and the inserted segment.
The right-side biopsy from each mouse was placed in 10% buffered formaldehyde (pH 7.3) for histological examination. From the left-side biopsy, the catheter segment was separated from the tissue, washed twice with phosphate-buffered saline (PBS) (8.1 mM Na2HPO4, 1.5 mM KH2PO4, 140 mM NaCl, pH 7.2) and placed in a sterile tube containing 1 ml of PBS. The tissue sample was placed in a tube and weighed, and a volume of pyrogen-free isotonic saline corresponding to four times the weight was added. The weight of the tissue samples varied between 125 and 160 mg.Histological examination. After fixation in formaldehyde, the biopsies were embedded in plastic (methylmethacrylaat-butylmethacrylaat) (Merck Schuchart, Hohenbrunn, Germany), sectioned, and stained with hematoxylin-eosin. Slides were examined for five histological features characteristic for tissue reactions after implantation of a foreign body (2). These were (i) infiltration of inflammatory cells, i.e., polymorphonuclear or mononuclear cells; (ii) presence of purulence, i.e., deposition of leukocytes with necrotic burdens; (iii) foreign-body giant-cell formation; (iv) fibrosis, characterized by inflammatory cells, fibroblasts, and newly formed collagen; and (v) encapsulation of the foreign body. Sections were scored independently by three of us (J. J. Boelens, J. L. Murk, and J. J. Weening), using a scale of 0 to 3, indicative of the grade of appearance of each feature: a feature was scored 0 when it was not observed and 3 when it was maximally present. At the time of judgement, none of the investigators knew which sample originated from which mouse. The scales were based on inspection of slides previously obtained from tissue samples taken from subcutaneously inserted SE or SEpvp segments in mice which received bacterial inocula ranging from 0 CFU (saline injection) to 1010 CFU of S. epidermidis RP62a along the inserts (6).
Quantitative culture of SE and SEpvp catheter segments. The tubes containing SE and SEpvp segments in 1 ml of PBS were sonicated for 30 s in a water bath sonicator (Bransonic B-2200 E4; 47, kHz, 205 W) to dislodge adherent bacteria. The number of viable S. epidermidis cells was assessed by quantitative culture of serial 10-fold dilutions of this PBS sonicate. Six aliquots of 10 µl of each dilution were spotted on a blood agar plate which was incubated overnight at 37°C. The remaining suspension was stored at 4°C. When no growth was observed on the blood agar plates, the stored suspension was centrifuged (2,200 × g, 10 min) and the pellet was resuspended in 100 µl of PBS and plated on blood agar. In addition, the sonicated segments were cultured in 80 ml of modified thioglycolate broth, consisting of 3% (wt/vol) thioglycolate containing 0.03% (wt/vol) polyanetholesulfonic acid, 1 M NaOH, and 0.5% Tween 80, for 72 h at 37°C. For statistical purposes, it was assumed that 1 CFU per 1-cm catheter segment had been present when no growth occurred on the blood agar plates and the catheter segment incubated in the broth was culture positive. The number of adherent S. epidermidis RP62a cells is expressed as number of CFU per catheter segment (1 cm).
Quantitative culture of the homogenates. Tubes containing the tissue sample in pyrogen-free isotonic saline were homogenized on ice with a tissue homogenizer (Tissue Tearer model 985-370; Biospec Products, Bartlesville, Okla.). After each homogenization, the homogenizer was carefully cleaned, disinfected by subsequently washing in 4% (wt/vol) sodium hypochloride-70% alcohol, and rinsed with pyrogen-free isotonic saline. Seventy microliters of the homogenates was serially 10-fold diluted, and six aliquots of 10 µl of undiluted homogenate and of each dilution were spotted on a blood agar plate, which was incubated overnight at 37°C. In addition, 50 µl of the homogenate was cultured in 80 ml of thioglycolate broth for 72 h at 37°C. For statistical purposes it was assumed that 1 CFU per 50 µl had been present when no growth occurred on the blood agar plates and the homogenate aliquot incubated in the broth was culture positive. The number of persisting S. epidermidis RP62a cells is expressed as number of CFU per gram.
Cytokine assays of the homogenates.
The total homogenates,
reduced by 120 µl for the quantitative culture, were diluted in 1 volume of lysis buffer (25) containing 1% Triton X-100, 150 mM NaCl, 30 mM Tris, 2 mM CaCl2, 2 mM MgCl2, 0.2% aprotin, and 0.2% leupeptin (pH 7.40) and incubated on ice for
1 h. Subsequently, the lysed homogenates were centrifuged at
130,000 × g for 15 min at 4°C to remove cell debris.
The cell-free supernatants were frozen at
80°C, thawed, centrifuged
at 5,000 × g to remove macroaggregates, and stored in
aliquots of 35 µl at
80°C until use. Levels of IL-1
(R&D
Systems, Minneapolis, Minn.), IL-1
(R&D Systems), and IL-4 (R&D
Systems) were measured with commercially available enzyme-linked
immunosorbent assay kits and expressed as picograms per milliliter of homogenate.
Statistical analysis.
All values are expressed as mean ± standard error. Two-sample comparisons were made by analysis of
variance (ANOVA), and comparisons between cytokine levels of groups
over time were made by ANOVA in a general linear model-general
factorial. The significance of differences between the frequencies of
categorical variables was determined using the
2 test. A
P value of <0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Development of biomaterial-associated infection.
In the saline
control mice, no abscess formation was seen. In wild-type mice after
injection of 106 CFU of S. epidermidis, abscess
formation was observed around SEpvp at all time points tested but not
around SE segments. In contrast, in IL-1R
/
mice
abscesses were found neither around SE segments nor around SEpvp
segments at any time point after inoculation with S. epidermidis (Fig. 1A).
|
/
mice significantly more
colonies were cultured from tissues surrounding SEpvp (22,000 ± 12,000 CFU/g) than from tissues surrounding SE (8,000 ± 9,000 CFU/g) (P < 0.05) at 2 days, and at 5 days all tissue
homogenates surrounding SEpvp were positive, while all tissue
homogenates surrounding SE were negative. At 14 days, however, five out
of six tissue homogenates from SEpvp implantation sites were culture
negative in IL-1R
/
mice. Thus, significantly fewer
(P < 0.05) tissues were culture positive in
IL-1R
/
mice than in wild-type mice around SEpvp at 14 days. The cultured S. epidermidis had the same antibiogram
as strain RP62a. No colonies were cultured from the tissue samples of
mice injected with saline.
SEpvp segments implanted in wild-type mice were significantly
more often culture positive for S. epidermidis RP62a than SE segments (7 of 18 versus 1 of 18; P = 0.01) (Fig. 1C).
In IL-1R
/
mice similar results were obtained (8 of 18 versus 3 of 18; P = 0.02). The cultured S. epidermidis had the same antibiogram as strain RP62a. In wild-type
mice, tissues surrounding SE and SEpvp (7 of 18 and 18 of 18, respectively) were significantly more often culture positive than the
corresponding segments (1 of 18 and 7 of 18, respectively)
(P < 0.05). Similarly, in IL-1R
/
mice,
tissues surrounding SE and SEpvp (10 of 18 and 13 of 18, respectively)
were significantly more often culture positive than the corresponding
segments (3 of 18 and 8 of 18, respectively) (P < 0.05). This indicates persistence of S. epidermidis in
tissue rather than on the catheter surface.
Hence, using an inoculum of 106 CFU of S. epidermidis, in IL-1R
/
mice neither abscess
formation nor persistent infection associated with SEpvp was induced,
while wild-type mice were highly susceptible to SEpvp-associated
abscess formation and infection. Bacteria persisted in the tissue
rather than being adherent on the catheter segment.
Histological examination of the inflammatory and foreign-body
reaction.
Five histological features characteristic for the tissue
inflammation and foreign-body response following the implantation of a
foreign body were scored independently by three investigators who were
blinded for the origin of the samples. The mean scores for these
histological features at each time point are shown in Fig.
2. Variation of scores between
investigators was always maximally 0.5 scale unit.
|
/
mice and wild-type mice showed only small differences (Fig. 2 and
3). In contrast, around SEpvp, the
foreign-body response was dramatically different in wild-type and
IL-1R
/
mice (Fig. 2 and 3). In wild-type mice, a
prolonged and intensified inflammatory status was observed around
SEpvp, characterized by the presence of purulence and a very strong
infiltration up to 14 days, by strong fibrosis, and by delayed
giant-cell formation and delayed encapsulation of the foreign body. In
contrast, around SEpvp implanted in IL-1R
/
mice, no
purulence was present, and a mild inflammation, weak fibrosis, and a
normal development of the foreign-body reaction were observed,
characterized by a layer containing giant cells bordering the implant
at 5 days and the presence of a fibrous capsule at 14 days (Fig. 2 and
3).
|
/
mice challenged
with S. epidermidis, a normal foreign-body reaction, similar
to that around SE implanted in wild-type mice challenged with S. epidermidis, was observed.
Induction of IL-1
, IL-1
, and IL-4.
IL-1
was
detectable at low levels in saline control wild-type and
IL-1R
/
mice (Fig. 4). In
wild-type mice injected with S. epidermidis, significantly
higher IL-1
levels were found in tissue surrounding SEpvp segments
than in tissue surrounding SE (P < 0.01 for the profile of IL-1
over time). In IL-1R
/
mice at 2 days, significantly higher IL-1
levels were found in tissue
surrounding the implanted SE (1,624 ± 529 versus 545 ± 211 pg/ml; P = 0.002) and in tissue surrounding SEpvp
(5,069 ± 2,478 versus 1,418 ± 763 pg/ml; P = 0.007) than in wild-type mice. At later time points no differences
in IL-1
levels between wild-type and IL-1R
/
mice
were detected around SEpvp segments. In tissues surrounding SE in
wild-type and IL-1R
/
mice, IL-1
levels were equal at
5 days but again were higher in IL-1R
/
mice at 14 days
(P < 0.01).
|
was detectable in saline control wild-type and
IL-1R
/
mice (Fig. 4). In mice inoculated with S. epidermidis, IL-1
levels around the implanted SE and SEpvp
segments increased up to 5 days and remained elevated up to 14 days. No
differences were found between IL-1
levels in tissues surrounding SE
and SEpvp or in tissues from wild-type and IL-1R
/
mice.
IL-4 was detectable in saline control wild-type and
IL-1R
/
mice (Fig. 4). In wild-type mice injected with
S. epidermidis, IL-4 levels were increased in tissue around
SE after 5 days, whereas in tissue surrounding SEpvp no increase was
found. The profile of IL-4 in tissue surrounding SE over time was
significantly higher (P = 0.025) (Fig. 4) than that in
tissue surrounding SEpvp. In tissues surrounding either SE or SEpvp
segments from IL-1R
/
, mice significantly higher
levels of IL-4 were detected than in wild-type mice (P < 0.01 for both) (Fig. 4).
| |
DISCUSSION |
|---|
|
|
|---|
Recently, we found sustained IL-1
production in murine tissues
surrounding subcutaneously implanted biomaterials infected with
S. epidermidis (9). In the present study, we
sought to determine the role of this locally produced IL-1 in the
pathogenesis of BAI. We demonstrated that IL-1R
/
mice
had no abscess formation and were less susceptible to persistent S. epidermidis infection associated with SEpvp catheters
than wild-type mice. The foreign-body reaction around SEpvp was delayed in wild-type mice but not in IL-1R
/
mice. These data
suggest that IL-1 plays a detrimental role in this experimental model
for BAI.
The IL-1 family consists of two agonist ligands, the potent
proinflammatory cytokines IL-1
and IL-1
, and an antagonist
ligand, IL-1R antagonist. IL-1
and IL-1
induce cellular effects
by binding to the type I IL-1R. The type II IL-1R has no signaling
properties but acts as a decoy receptor (3, 20, 51). Hence,
mice deficient in IL-1R type I are incapable of responding to either
IL-1
or IL-1
(24). The IL-1 family regulates a number
of immunological, physiological, and pathophysiological responses. IL-1
has an important role in the host response against bacterial infections
(19, 20). However, IL-1 action is tightly regulated, and
there seems to be a delicate balance between the beneficial local
activity of IL-1 and potentially harmful excessive local or systemic
IL-1 activity. Indeed, blockage of IL-1 activity resulted in increased susceptibility to infection (23, 26, 34, 53). On the
other hand, protracted and/or systemic production of IL-1 is involved in a variety of inflammatory diseases, such as rheumatic or septic arthritis, pancreatitis, septic shock, and acute respiratory distress syndrome (19, 20, 27, 40). Blocking of IL-1 activity by administration of IL-1R antagonist reduced tissue damage in
experimental arthritis (41, 42, 49, 55) and pancreatitis
(43-45) and reduced mortality in experimental septic shock
models (1, 22, 38). Additionally, IL-1 is assumed to have a
role in bioincompatibility (9, 10, 12, 16, 18). In the
present study, the enhanced and protracted inflammatory response due to
the combined effect of SEpvp and S. epidermidis observed in
wild-type mice was strongly attenuated in IL-1R
/
mice.
The latter mice did not show abscess formation and were not susceptible
to persistent S. epidermidis infection associated with
SEpvp. As shown in previous work by us, tissues around SEpvp implanted
in wild-type mice remained positive for up to 60 days (7,
9), while five out of six tissues around SEpvp implanted in
IL-1R
/
are negative at 14 days. The exaggerated and
protracted local IL-1 response around SEpvp in wild-type mice,
resulting in abscess formation and delay of the normal foreign-body
reaction (2), apparently was beneficial for survival of the
relatively avirulent S. epidermidis.
After initial culture positivity (2 days), the SEpvp segments
themselves became culture negative after 14 days, in the wild-type mice
as well as in the IL-1R
/
mice. However, the tissue
around SEpvp in the IL-1R
/
mice remained culture
positive. In a previous study similar results were obtained with SEpvp
segments to which S. epidermidis (3 × 103
CFU per cm) was added prior to implantation (6), indicating that the persistence in the tissue was not due to the mode of inoculation. Our findings are discordant with the contention that adherence to and growth of bacteria on the biomaterial surface are of
decisive importance in the pathogenesis of BAI (5, 50) but
suggest that the niche for the persisting S. epidermidis is not the implanted SEpvp segment but rather the surrounding tissue.
The bacterial survival in the present study could have been associated
with the abscess (17, 35) along the subcutaneously implanted
SEpvp segment rather than with adherence to the catheter surface.
Alternatively, exaggerated and protracted local inflammation, as
observed in wild-type mice carrying SEpvp segments, may compromise the
resolution of an infection by priming for intracellular and extracellular growth of bacteria exceeding the clearance ability of the
host. Kanangat et al. (30) reported that high concentrations of lipopolysaccharide, IL-1
, IL-6, and tumor necrosis factor alpha
stimulated intracellular growth in monocytes as well as extracellular
growth of Staphylococcus aureus, Pseudomonas
aeruginosa, and an Acinetobacter sp., which are all
important nosocomial pathogens (30). Observation in humans
support a role for increased proinflammation in persistent infection:
(i) patients suffering from acute respiratory distress syndrome, caused
by acute development of diffuse lung inflammation, have
persistently elevated levels of proinflammatory cytokines associated
with an increased rate of nosocomial infections (27, 40);
(ii) patients with long-term exposure to intravascular catheters had
exacerbated complications associated with sepsis (37); and
(iii) patients who had an extracorporal circulation (11), as
well as patients undergoing hemodialysis (28, 48), with
enhanced levels of circulating proinflammatory cytokines were highly susceptible.
In tissues surrounding SE and SEpvp, the IL-1
production was
significantly higher in IL-1R
/
mice than in wild-type
mice. Similarly, in a model of acute pancreatitis (43-45),
IL-1R
/
mice had higher IL-1
levels than wild-type
mice, suggesting that a negative feedback loop exists between IL-1R and
IL-1
production. It should be noted, however, that IL-1
concentrations were not increased in IL-1R
/
mice.
Therefore, further studies are warranted to dissect the mechanism
involved in elevating tissue IL-1
levels during BAI in
IL-1R
/
mice.
The protracted increased IL-1
levels around SEpvp implanted in
S. epidermidis-challenged wild-type mice were associated
with a reduction in IL-4 production and a delay in foreign body
development characterized by the presence of foreign-body giant-cell
formation and encapsulation not earlier than at 14 days. Conversely, in the IL-1R
/
mice, increased IL-4 levels and a layer of
foreign-body giant cells were present around SEpvp at 5 days, as was
the case for S. epidermidis-challenged wild-type mice with
SE and for saline-injected wild-type mice with implanted SE or SEpvp
segments (data not shown). Apparently, IL-4 is associated with
macrophage fusion and the onset of the foreign-body reaction in vivo.
This confirms the relevance of similar data obtained by others
in vitro (21, 29, 31, 33, 39). In addition, the enhanced (in
comparison to in wild-type mice) production of IL-4 around SEpvp in our
IL-1R
/
mice despite the high levels of IL-1
is
concordant with similar results obtained in a leishmanias infection
model (47) and suggests a role for IL-1 in the
down-regulation of IL-4 production in vivo in wild-type mice.
Implantation of SEpvp modulated the inflammatory environment in such a
way that it primed for bioincompatibility reactions in the presence of
S. epidermidis, resulting in enhanced leukocyte activation
and persistent infection. Enhancement of the inflammatory response in
the presence of bacteria is probably not restricted to SEpvp. Exposure
of human monocytes or polymorphonuclear cells to biomaterials in vitro
induced the production of IL-1
, tumor necrosis factor alpha, and
IL-6 (10, 12, 16, 52). Differences in inducing properties
between various biomaterials became apparent only in the presence of
lipopolysaccharide, a major cell wall component of gram-negative
bacteria (10, 12, 16, 52). This implies that in a
material-dependent way, the presence of bacteria or bacterial
components can modulate the inflammatory tissue reaction in response to
the implanted biomaterial. For biocompatibility a delicately balanced
immune response is required. This balance apparently is strictly
regulated, and when it is disturbed, an inappropriately strong reaction
and pathology will follow. Our in vivo experiments showed that IL-1
might be an important player in this bioincompatibility.
In conclusion, BAI in the SEpvp model was associated with an
exaggerated and protracted local IL-1
and IL-1
response. Blocking of IL-1 effects resulted in a reduced susceptibility to BAI and a
normal foreign-body reaction, suggesting a role for high IL-1 levels in
compromising the host by stimulating bacterial persistence and in
inhibiting IL-4 production. Our results suggest an important role for
the host response to various biomaterials in the pathogenesis of BAI,
rather than for the extent of adherence of bacteria to biomaterial.
Local inhibition of IL-1 activity may be of benefit to the host as an
adjunctive therapy for infections associated with biomaterials.
| |
ACKNOWLEDGMENT |
|---|
T. van der Poll is a fellow of the Royal Netherlands Academy of Arts and Sciences.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Dept. of Pediatrics, P.O. Box 9600, J6-Q-208, 2300 RC Leiden, The Netherlands. Phone: 31 71 5262824. Fax: 31 71 5248198. E-mail: boelensjj{at}yahoo.com.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aiura, K., J. A. Gelfand, G. Wakabayashi, M. Callahan, J. F. Burke, J. Thomson, and C. A. Dinarello. 1991. Interleukin-1 receptor antagonist blocks Staphylococcal induced shock in rabbits. Cytokine 3:498. |
| 2. | Anderson, J. M. 1988. Inflammatory response to implants. Trans. Am. Soc. Artif. Intern. Organs 34:101-107. |
| 3. | Arend, W., M. Malyak, C. Guthridge, and C. Gabay. 1998. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16:27-55[CrossRef][Medline]. |
| 4. | Bach, A., H. Bohrer, J. Motsch, E. Martin, H. K. Geiss, and H. G. Sonntag. 1993. Prevention of catheter-related infections by antiseptic bonding. J. Surg. Res. 55:640-646[CrossRef][Medline]. |
| 5. | Bisno, A., and F. Waldvogel. 1994. Infections associated with indwelling medical devices, 2nd ed. American Society for Microbiology, Washington, D.C. |
| 6. | Boelens, J., S. A. Zaat, J. Meeldijk, and J. Dankert. 2000. Subcutaneous abscess formation around catheters induced by viable and non-viable staphylococcus epidermidis as well as by small amounts of bacterial cell wall components. J. Biomed. Mater. Res. 50:546-556[CrossRef][Medline]. |
| 7. | Boelens, J. J., J. Dankert, J. L. Murk, J. J. Weening, T. van der Poll, K. P. Dingemans, L. Koole, J. D. Laman, and S. A. Zaat. 2000. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J. Infect. Dis. 181:1337-1349[CrossRef][Medline]. |
| 8. |
Boelens, J. J.,
W. F. Tan,
J. Dankert, and S. A. J. Zaat.
2000.
Antibacterial activity of antibiotic-soaked polyvinylpyrrolidone-grafted silicon elastomer hydrocephalus shunts.
J. Antimicrob. Chemother.
45:221-224 |
| 9. |
Boelens, J. J.,
S. A. J. Zaat,
J. L. Murk,
J. J. Weening,
T. van der Poll, and J. Dankert.
2000.
Enhanced susceptibility to subcutaneous abscess formation and persistent infection around catheters is associated with sustained interleukin-1 levels.
Infect. Immun.
68:1692-1695 |
| 10. | Bonfield, T. L., and J. M. Anderson. 1993. Functional versus quantitative comparison of IL-1 beta from monocytes/macrophages on biomedical polymers. J. Biomed. Mater. Res. 27:1195-1199[CrossRef][Medline]. |
| 11. | Cameron, D. 1996. Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors. J. Cardiovasc. Pharmacol. 27(Suppl.):S1-S5. |
| 12. | Cardona, M. A., R. L. Simmons, and S. S. Kaplan. 1992. TNF and IL-1 generation by human monocytes in response to biomaterials. J. Biomed. Mater. Res. 26:851-859[CrossRef][Medline]. |
| 13. |
Christensen, G. D.,
W. A. Simpson,
A. L. Bisno, and E. H. Beachey.
1982.
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.
Infect. Immun.
37:318-326 |
| 14. |
Christensen, G. D.,
W. A. Simpson,
A. L. Bisno, and E. H. Beachey.
1983.
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis.
Infect. Immun.
40:407-410 |
| 15. |
Christensen, G. D.,
W. A. Simpson,
J. J. Younger,
L. M. Baddour,
F. F. Barrett,
D. M. Melton, and E. H. Beachey.
1985.
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.
J. Clin. Microbiol.
22:996-1006 |
| 16. | DeFife, K. M., J. K. Yun, A. Azeez, S. Stack, K. Ishihara, N. Nakabayashi, E. Colton, and J. M. Anderson. 1995. Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J. Biomed. Mater. Res. 29:431-439[CrossRef][Medline]. |
| 17. | Deighton, M. A., R. Borland, and J. A. Capstick. 1996. Virulence of Staphylococcus epidermidis in a mouse model: significance of extracellular slime. Epidemiol. Infect. 117:267-280[Medline]. |
| 18. | Dinarello, C. A. 1990. Cytokines and biocompatibility. Blood Purification 8:208-213[Medline]. |
| 19. | Dinarello, C. A. 1992. Role of interleukine-1 in infectious diseases. Immunol. Rev. 127:119-146[CrossRef][Medline]. |
| 20. |
Dinarello, C. A.
1996.
Biologic basis for interleukin-1 in disease.
Blood
87:2095-2147 |
| 21. | Dugast, C., A. Gaudin, and L. Toujas. 1997. Generation of multinucleated giant cells by culture of monocyte-derived macrophages with IL-4. J. Leukoc. Biol. 61:517-521[Abstract]. |
| 22. | Everaerdt, B., P. Brouckaert, and W. Fiers. 1994. Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice. J. Immunol. 152:5041-5049[Abstract]. |
| 23. |
Garcia, M., and C. A. Dinarello.
1993.
The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.
Infect. Immun.
61:926-932 |
| 24. | Glaccum, M., K. Stocking, K. Charrier, J. Smith, C. Willis, C. Maliszewski, D. J. Livingstone, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypical and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159:3364-3371[Abstract]. |
| 25. | Greenberger, M., R. Streiter, R. Goodman, and T. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155:722-729[Abstract]. |
| 26. | Havell, E., L. Moldawer, D. Helfgott, P. Kilian, and P. Sehgal. 1992. Type I IL-1 receptor blockade exacerbates murine listeriosis. J. Immunol. 148:1486-1492[Abstract]. |
| 27. |
Headley, A.,
E. Tolley, and G. Meduri.
1997.
Infections and the inflammatory response in acute respiratory distress syndrome.
Chest
111:1306-1321 |
| 28. | Herbelin, A., P. Urena, T. Ngugen, J. Zingraff, and B. Descamps-Latscha. 1991. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 39:954-960[Medline]. |
| 29. | Jenney, C., K. DeFife, E. Colton, and J. M. Anderson. 1998. Human monocyte/macrophage adhesion, macrophage motility, and IL-4-induced foreign body giant cell formation on silane-modified surfaces in vitro. J. Biomed. Mater. Res. 41:171-184[CrossRef][Medline]. |
| 30. |
Kanangat, S.,
G. Meduri,
E. Tolley,
D. Patterson,
C. Meduri,
C. Pak,
J. P. Griffin,
M. S. Bronze, and D. R. Schaberg.
1999.
Effects of cytokines and endotoxin on the intracellular growth of bacteria.
Infect. Immun.
67:2834-2840 |
| 31. | Kao, W. J., Q. H. Zhao, A. Hiltner, and J. M. Anderson. 1994. Theoretical analysis of in vivo macrophage adhesion and foreign body giant cell formation on polydimethylsiloxane, low density polyethylene, and polyetherurethanes. J. Biomed. Mater. Res. 28:73-79[CrossRef][Medline]. |
| 32. |
Kaplan, S. S.,
R. P. Heine, and R. L. Simmons.
1999.
Definsins impair phagocytic killing by neutrophils in biomaterial-related infection.
Infect. Immun.
67:1640-1645 |
| 33. |
Kazazi, F.,
J. Chang,
A. Lopez,
M. Vadas, and A. Cunningham.
1994.
Interleukin-4 and human immune deficiency virus stimulate LFA-1-ICAM-1-mediated aggregation of monocytes and subsequent giant cell formation.
J. Gen. Virol.
75:2795-2802 |
| 34. |
Kozak, W.,
H. Zheng,
C. Conn,
D. Soszynski,
L. van der Ploeg, and M. Kluger.
1995.
Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1beta-deficient mice.
Am. J. Physiol.
269:R969-R977 |
| 35. | Long, J., and F. Kapral. 1993. Host response to coagulase-negative staphylococci in abscesses induced within mice. J. Med. Microbiol. 39:191-195[Abstract]. |
| 36. |
Maki, D. G.,
S. M. Stolz,
S. Wheeler, and L. A. Mermel.
1997.
Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Ann. Intern. Med.
127:257-266 |
| 37. | Martin, L., T. Varv, P. Davis, B. Munger, J. Lynch, S. Spangler, and D. G. Remick. 1991. Intravascular plastic catheters. How they potentiate tumar necrosis factor release and exacerbate complications associated with sepsis. Arch. Surg. 126:1087-1093[Abstract]. |
| 38. |
McIntyre, K.,
G. Stepan,
D. Kolinsky,
W. Benjamin,
J. Plocinski,
K. Kaffka,
R. A. Campen,
R. Chizzonite, and P. L. Kilian.
1991.
Interleukin-1 receptor antagonist blocks acute inflammatory response to IL-1 and other agents.
J. Exp. Med.
173:931-939 |
| 39. | McNally, A. K., and J. M. Anderson. 1995. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Am. J. Pathol. 147:1487-1499[Abstract]. |
| 40. | Meduri, G. 1996. The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur. Respir. 9:2650-2670. |
| 41. | Miller, L., S. Isa, E. Vannier, K. Georgilis, A. Steer, and C. A. Dinarello. 1992. Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J. Clin. Invest. 90:906-912. |
| 42. | Miller, L., E. A. Lynch, S. Isa, J. Logan, and C. A. Dinarello. 1993. Balance of synovial fluid IL-1beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341:146-148[CrossRef][Medline]. |
| 43. | Norman, J., G. Fink, C. Sexton, and G. Carter. 1995. Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1beta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J. Surg. Res. 63:231-236. |
| 44. | Norman, J., M. Franz, J. Messina, P. Fabri, W. Gower, and L. Carey. 1995. Decreased mortality of severe acute pancreatitis after proximal cytokine blockage. Ann. Surg. 221:625-631[Medline]. |
| 45. | Norman, J., M. Franz, J. Messina, A. Riker, P. Fabri, A. Rosemurgy, and G. R. Gower. 1995. Interleukin-1 receptor antagonist decreases severity of acute pancreatitis. Surgery 117:648-655[CrossRef][Medline]. |
| 46. |
Raad, I.,
R. Darouiche,
J. Dupuis,
D. Abi-Said,
A. Gabrielli,
R. Hachem,
M. Wall,
R. Harris,
J. Jones,
A. Buzaid,
C. Robertson,
S. Shenaq,
P. Curling,
T. Burke, and C. Ericsson.
1997.
Central venous catheters coated with minocycline and prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial.
Ann. Intern. Med.
127:267-274 |
| 47. | Satoskar, A., M. Okano, S. Connaughton, A. Raisanen-Sololwski, J. David, and M. Labow. 1998. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 28:2066-2074[CrossRef][Medline]. |
| 48. | Schindler, R., G. Lonnemann, S. Shaldon, K. Koch, and C. A. Dinarello. 1990. Transcription, not synthesis of interleukin-1 and tumor necrosis factor by complement. Kidney Int. 37:85-93[Medline]. |
| 49. |
Schwab, J.,
S. Anderle,
R. Brown,
F. Dalldorf, and J. Thomson.
1991.
Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell-wall induced arthritis in rats.
Infect. Immun.
59:4436-4442 |
| 50. | Seifert, H., B. Jansen, and B. Farr. 1997. Catheter-related infections, 1st ed. Marcel Dekker Press, New York, N.Y. |
| 51. | Sims, J., J. Giri, and S. Dowere. 1994. The two interleukin-1 receptors play different roles in IL-1 action. Clin. Immunol. Immunopathol. 72:9-14[CrossRef][Medline]. |
| 52. | Swartbol, P., L. Truedsson, H. Parsson, and L. Norgren. 1997. Tumor necrosis factor-alpha and interleukin-6 release from white blood cells induced by different graft materials in vitro are affected by pentoxifylline and iloprost. J. Biomed. Mater. Res. 36:400-406[CrossRef][Medline]. |
| 53. |
van der Meer, J.,
M. Barza,
S. Wolff, and C. A. Dinarello.
1988.
A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.
Proc. Natl. Acad. Sci. USA
85:1620-1623 |
| 54. | Vaudaux, P., G. Grau, E. Huggler, F. Schumacher-Perdreau, F. Fiedler, F. A. Waldvogel, and D. P. Lew. 1992. Contribution of tumor necrosis factor to host defense against staphylococci in a guinea pig model of foreign body infections. J. Infect. Dis. 166:58-64[Medline]. |
| 55. | Wooley, P., J. Whalen, D. Chapman, A. Berger, D. Aspar, K. Richard, and N. D. Staite. 1993. The effect of an interleukin-1 receptor antagonist protein on Type II cologen and antigen-induced arthritis in mice. Arthritis Rheum. 36:1305-1314[Medline]. |
| 56. | Zimmerli, W., F. Waldvogel, P. Vaudaux, and H. E. Nydegger. 1982. Pathogenesis of foreign body infection: description and characteristics of an animal study. J. Infect. Dis. 146:487-497[Medline]. |
| 57. | Zimmerli, W., and F. Waldvogel. 1984. Pathogenesis of foreign body infection. J. Clin. Investig. 73:1191-1200. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|